Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets and antiphospholipid antibodies

S J Machin1

  • 1Haematology Department, University College London, UK.

Lupus
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Platelets play a complex role in antiphospholipid syndrome. Antiphospholipid antibodies binding to platelets may cause low platelet counts and increased clotting risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem<sup>™</sup> PT).

International journal of laboratory hematology·2017
Same author

ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate.

International journal of laboratory hematology·2017
Same author

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential Thrombocythaemia.

Leukemia & lymphoma·2016
Same author

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.

Journal of thrombosis and haemostasis : JTH·2015
Same author

ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features.

International journal of laboratory hematology·2015

Area of Science:

  • Hematology
  • Immunology
  • Thrombosis

Background:

  • Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of blood clots.
  • The precise mechanisms by which antiphospholipid antibodies (aPL) contribute to thrombotic events in APS are not fully elucidated.
  • Platelets are increasingly recognized as key players in the pathogenesis of APS.

Purpose of the Study:

  • To investigate the complex role of platelets in antiphospholipid syndrome.
  • To understand the pathogenic significance of antiphospholipid antibody binding to platelets.
  • To explore the consequences of this interaction on platelet count and hemostatic activation.

Main Methods:

  • Review of existing literature on platelet function in APS.

Related Experiment Videos

  • Analysis of studies investigating antiphospholipid antibody interactions with platelet surfaces.
  • Examination of evidence linking aPL-platelet binding to clinical outcomes.

    • Main Results:

    • Antiphospholipid antibodies bind to specific targets on the platelet membrane.
    • This binding can lead to a reduction in platelet count (thrombocytopenia).
    • The interaction promotes further activation of the hemostatic system, potentially contributing to thrombosis.

    Conclusions:

    • Platelet involvement in APS is multifaceted and significant.
    • Antiphospholipid antibody binding to platelets is a key pathogenic event.
    • This interaction contributes to both thrombocytopenia and hypercoagulability in antiphospholipid syndrome.